Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
62M
-
Number of holders
-
114
-
Total 13F shares, excl. options
-
33.6M
-
Shares change
-
+761K
-
Total reported value, excl. options
-
$638M
-
Value change
-
+$15.1M
-
Put/Call ratio
-
0.62
-
Number of buys
-
55
-
Number of sells
-
-46
-
Price
-
$19.00
Significant Holders of MACROGENICS INC - Common Stock, par value $0.01 per share (MGNX) as of Q4 2017
131 filings reported holding MGNX - MACROGENICS INC - Common Stock, par value $0.01 per share as of Q4 2017.
MACROGENICS INC - Common Stock, par value $0.01 per share (MGNX) has 114 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.6M shares
of 62M outstanding shares and own 54.24% of the company stock.
Largest 10 shareholders include OppenheimerFunds, Inc. (3.93M shares), FMR LLC (3.64M shares), BlackRock Inc. (2.65M shares), BB BIOTECH AG (2.6M shares), Boxer Capital, LLC (2.2M shares), Vanguard Group Inc (1.56M shares), EcoR1 Capital, LLC (1.14M shares), Point72 Asset Management, L.P. (1.08M shares), INTERWEST VENTURE MANAGEMENT CO (1.07M shares), and STATE STREET CORP (1.05M shares).
This table shows the top 114 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.